Showing results (1-10 of 76) with videos related to
Sort By:
Pageof 8
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|January 5, 2019
[Anti-hepatitis C Virus Strategy Targeting the Entry Steps]Masayoshi FukasawaYakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|May 3, 2014
[Claudin 1 as a target for anti-hepatitis C virus strategy]Masayoshi FukasawaUirusu|January 1, 2015
Anti-hepatitis C virus strategy targeting host entry factor claudin-1Masayoshi FukasawaBiological & Pharmaceutical Bulletin|March 2, 2010
Cellular lipid droplets and hepatitis C virus life cycleMasayoshi FukasawaFEBS Letters|June 25, 2013
Selective control of SNARE recycling by Golgi retentionMasayoshi Fukasawa, Anda Cornea, Oleg VarlamovJournal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|September 2, 2020
Several catechins and flavonols from green tea inhibit severe fever with thrombocytopenia syndrome virus infection in vitroMotohiko Ogawa, Masayuki Shimojima, Masayuki Saijo, et al.Biochemical and Biophysical Research Communications|September 24, 2013
A class II phosphoinositide 3-kinase plays an indispensable role in hepatitis C virus replicationTomohiko Maehama, Masayoshi Fukasawa, Tomoko Date, et al.Annals of the New York Academy of Sciences|April 18, 2017
Claudin-targeted drug development using anti-claudin monoclonal antibodies to treat hepatitis and cancerYosuke Hashimoto, Masayoshi Fukasawa, Hiroki Kuniyasu, et al.Virology|March 12, 2019
Claudin-1 inhibits human parainfluenza virus type 2 disseminationNatsuko Yumine, Yusuke Matsumoto, Keisuke Ohta, et al.Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|April 10, 2018
Caffeic acid, a coffee-related organic acid, inhibits infection by severe fever with thrombocytopenia syndrome virus in vitroMotohiko Ogawa, Yoshitaka Shirasago, Shuji Ando, et al.Pageof 8